Analysts’ Weekly Ratings Changes for MetLife (MET)

A number of firms have modified their ratings and price targets on shares of MetLife (NYSE: MET) recently:

• 8/24/2026 – MetLife had its “mixed” rating reaffirmed by Evercore Inc.
• 8/24/2026 – MetLife had its price target raised by Morgan Stanley from $103.00 to $111.00. They now have an “overweight” rating on the stock.
• 8/22/2026 – MetLife was upgraded by Wall Street Zen from “hold” to “buy”.
• 8/19/2026 – MetLife had its price target raised by Wells Fargo & Company from $101.00 to $109.00. They now have an “overweight” rating on the stock.
• 8/11/2026 – MetLife had its price target raised by JPMorgan Chase & Co. from $106.00 to $108.00. They now have an “overweight” rating on the stock.
• 8/11/2026 – MetLife had its price target raised by Keefe, Bruyette & Woods from $105.00 to $108.00. They now have an “outperform” rating on the stock.
• 8/6/2026 – MetLife had its price target raised by Barclays PLC from $94.00 to $97.00. They now have an “overweight” rating on the stock.
• 7/22/2026 – MetLife had its price target raised by TD Cowen from $87.00 to $105.00. They now have a “buy” rating on the stock.
• 7/21/2026 – MetLife had its price target raised by JPMorgan Chase & Co. from $96.00 to $106.00. They now have an “overweight” rating on the stock.
• 7/15/2026 – MetLife was given a new $103.00 price target by Atlantic Securities.
• 7/13/2026 – MetLife had its price target raised by Keefe, Bruyette & Woods from $98.00 to $105.00. They now have an “outperform” rating on the stock.
• 7/10/2026 – MetLife had its price target raised by Jefferies Financial Group Inc. from $97.00 to $103.00. They now have a “buy” rating on the stock.
• 7/9/2026 – MetLife had its price target raised by Wells Fargo & Company from $95.00 to $101.00. They now have an “overweight” rating on the stock.
• 7/9/2026 – MetLife had its price target raised by Mizuho from $95.00 to $102.00. They now have an “outperform” rating on the stock.
• 7/8/2026 – MetLife had its price target raised by UBS Group AG from $102.00 to $105.00. They now have a “buy” rating on the stock.
• 7/7/2026 – MetLife had its price target raised by Barclays PLC from $93.00 to $94.00. They now have an “overweight” rating on the stock.
• 7/6/2026 – MetLife had its price target raised by Morgan Stanley from $93.00 to $103.00. They now have an “overweight” rating on the stock.

MetLife Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 8th. Shareholders of record on Tuesday, August 4th will be issued a dividend of $0.5925 per share. The ex-dividend date of this dividend is Tuesday, August 4th. This represents a $2.37 dividend on an annualized basis and a yield of 2.5%. MetLife’s payout ratio is presently 45.40%.

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.